- Children's Motrin - Caplets and Chewables
- Children's Tylenol - Meltaways
- Benadryl - Tablets
- Extra Strength Tylenol - Caplets, Cool Caplets, EZ Tablets and Rapid Release Gelcaps
- Motrin IB - Caplets and Tablets
- Regular Strength Tylenol - Caplets and Tablets
- Rolaids - Chewables
- Simply Sleep - Caplets
- St. Joseph Aspirin - Chewables and Tablets
- Tylenol 8 Hour - Caplets
- Tylenol Arthritis - Caplets and Geltabs
- Tylenol PM - Caplets, Geltabs and Rapid Release Gelcaps
"We are aware of the complaint information available to your company, the sequence of events, and the extent of your firm's follow up measures during this period. We have concluded that your company did not conduct a timely, comprehensive investigation.
Your initial investigation into the root cause of the odor was unjustifiably delayed and terminated prematurely. Numerous complaints were received over a four month period in 2008 before they were considered a trend and before actions were initiated to determine the root cause. When microbiological testing in August 2008 did not support an initial speculation that microbial contamination was the root cause of the odor, the investigation was closed. No other possible root causes were pursued. Your firm lacked adequate justification for this decision."
"The Agency is concerned about the response of Johnson & Johnson (J&J) to this matter. It appears that when J&J became aware of FDA's concerns about the thoroughness and timeliness of McNeil's investigation, whether all potentially affected products had been identified, and whether the recall was adequate in scope, J&J did not take appropriate actions to resolve these issues. Corporate management has the responsibility to ensure the quality, safety, and integrity of its products. Neither upper management at J&J nor at McNeil Consumer Healthcare assured timely investigation and resolution of the issues."
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.